statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment

Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment PR Newswire...

Hoth Therapeutics Expands Clinical Trial for Cancer Patients

Hoth Therapeutics Expands Clinical Trial for Cancer Patients Hoth Therapeutics Expands Clinical Trial for Cancer Patients PR Newswire NEW YORK, July 16, 2024 Three New Sites Join HT-001 Trial, GW...

Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery

Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery Hoth Therapeutics Announces Joint Development...

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024 Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024 PR Newswire NEW YORK, May 1, 2024 NEW YORK...

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for...

Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds

Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds PR Newswire NEW YORK, March 27, 2024...

Hoth Therapeutics announces positive preclinical research in Alzheimer's

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ

Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's...

Hoth Therapeutics, Inc. (NASDAQ:HOTH) Short Interest Down 9.9% in February

Hoth Therapeutics, Inc. (NASDAQ:HOTH  Get Free Report) was the recipient of a large decline in short interest during the month of February. As of February 29th, there was short interest...

Why Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday?

Hoth Therapeutics reveals preclinical findings on HT-ALZ, a potential Alzheimer's therapeutic targeting the Substance P/Neurokinin 1 Receptor pathway. HT-ALZ exhibits significant reductions in...

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.

Volume	945,320.00
52-Wk High	$3.37
52-Wk Low	$0.72

HOTH Hoth Therapeutics Inc

About

Feed

News

Fundamentals